Patents by Inventor D. Hubbard

D. Hubbard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975592
    Abstract: An interface system for connecting a vehicle and a transport climate control system (TCCS) is disclosed. The interface system includes a two-way communication interface that connects a vehicle electrical system (VES) controller and a TCCS controller. The interface system also includes a power interface that connects a vehicle energy source of the VES to the TCCS and a TCCS energy source of the TCCS to the VES. The two-way communication interface is configured to distribute a TCCS status from the TCCS controller to the VES controller, and is configured to distribute a VES status from the VES controller to the TCCS controller. The power interface is configured to distribute power from the vehicle energy source to the TCCS when a VES instruction is received, and distribute power from the TCCS energy source to the VES when a TCCS instruction is received.
    Type: Grant
    Filed: August 16, 2022
    Date of Patent: May 7, 2024
    Assignee: Thermo King LLC
    Inventors: Ryan Wayne Schumacher, Mark D. Leasure, Nicholas Allan Cregan, Michael James Vanous, Matthew Srnec, Wallace Stephen Hubbard
  • Publication number: 20240141029
    Abstract: Provided herein are methods and compositions related to the treatment of sepsis using anti-ANGPTL3 antibodies.
    Type: Application
    Filed: March 2, 2022
    Publication date: May 2, 2024
    Inventors: Brian K. Hubbard, Michael H. Serrano-Wu, Charles D. Meyers
  • Publication number: 20240107981
    Abstract: A grooming tool for use on an animal includes a base arrangement sized for grasping by a human hand. A first section of grooming members is secured to the base arrangement and includes flexible members. A second section of grooming members is spaced from the first section and includes flexible members. A third section of rigid grooming members are positioned between the first section and second section of grooming members. The tool can include a grip assembly having a pivotable grip member.
    Type: Application
    Filed: December 2, 2021
    Publication date: April 4, 2024
    Applicant: Spectrum Brands, Inc.
    Inventors: William D. HIMES, Kathryn E. YEE, Jewel M. CARY, William P. Robertson, Jessica E, HUBBARD, Chris STOLL
  • Patent number: 11724010
    Abstract: The present invention is directed to an adherent resorbable matrix for use in surgical applications. The adherent resorbable matrix includes a biocompatible adherent material including chitosan.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: August 15, 2023
    Assignee: Integra LifeSciences Corporation
    Inventors: Gregory J. Pomrink, Paul K. Alkema, Raymond D. Hubbard, Riyesh Menon
  • Publication number: 20210085836
    Abstract: The present invention is directed to an adherent resorbable matrix for use in surgical applications. The adherent resorbable matrix includes a biocompatible adherent material including chitosan.
    Type: Application
    Filed: October 6, 2020
    Publication date: March 25, 2021
    Inventors: Gregory J. Pomrink, Paul K. Alkema, Raymond D. Hubbard, Riyesh Menon
  • Patent number: 10806833
    Abstract: The present invention is directed to an adherent resorbable matrix for use in surgical applications. The adherent resorbable matrix includes a biocompatible adherent material including chitosan.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: October 20, 2020
    Assignee: Integra LifeSciences Corporation
    Inventors: Gregory J. Pomrink, Paul K. Alkema, Raymond D. Hubbard, Riyesh Menon
  • Patent number: 9561231
    Abstract: The present invention provides for compounds of formula (I) wherein A1, A2, A3, A4, J, and X3 have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula I.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: February 7, 2017
    Assignee: AbbVie Inc.
    Inventors: Robert D. Hubbard, Le Wang, Chang H Park, Chaohong Sun, Keith F McDaniel, John K Pratt, Todd N Soltwedel, Michael D Wendt, James H Holms, Dachun Liu, George S Sheppard
  • Patent number: 9554650
    Abstract: A weight distributing chair stabilizing device for use in stabilizing a chair having at least a pair of spaced apart support members includes a plurality of stabilizing members, each having a planar bottom side configured to engage a ground surface and an opposed top side configured to receive a respective support member of the chair. The top side of each stabilizing member defines a linear channel extending between opposed peripheral edges of the top side, the channel being configured to selectively receive a respective chair support member therein. The stabilizing members may be a set of four circular discs although stabilizing members having other shape configurations would also work. When equally spaced apart on a ground surface, the support members of the chair may be positioned thereon and, as a result, the weight of the chair is equally distributed so as to stabilize the chair even on soft ground.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: January 31, 2017
    Inventors: Roland C. Hubbard, Sr., Craig D. Hubbard, Antonio K. Hubbard
  • Patent number: 9493411
    Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, and R10 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: November 15, 2016
    Assignee: AbbVie Inc.
    Inventors: Lisa A. Hasvold, John Pratt, Keith F. McDaniel, George S. Sheppard, Dachun Liu, Steven W. Elmore, Robert D. Hubbard
  • Publication number: 20140275079
    Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, and R10 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Inventors: Lisa A. Hasvold, John Pratt, Keith F. McDaniel, George S. Sheppard, Dachun Liu, Steven W. Elmore, Robert D. Hubbard
  • Publication number: 20130331382
    Abstract: The present invention provides for compounds of formula (I) wherein A1, A2, A3, A4, J, and X3 have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula I.
    Type: Application
    Filed: March 12, 2013
    Publication date: December 12, 2013
    Inventors: Robert D. HUBBARD, Le WANG, Chang H. PARK, Chaohong SUN, Keith F. McDANIEL, John K. PRATT, Todd N. SOLTWEDEL, Michael D. WENDT, John H. HOLMS, Dachun LIU, George S. SHEPPARD
  • Patent number: 8067409
    Abstract: Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: November 29, 2011
    Assignee: Abbott Laboratories
    Inventors: Nwe Y. Ba-Maung, Randy L. Bell, Richard F. Clark, Scott A. Erickson, Steve D. Fidanze, Robert D. Hubbard, Robert A. Mantei, George S. Sheppard, Bryan K. Sorensen, Gary T. Wang, Jieyi Wang
  • Patent number: 7772231
    Abstract: Compounds of formula (25) that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: August 10, 2010
    Assignee: Abbott Laboratories
    Inventors: George S. Sheppard, Gary T. Wang, Fabio Palazzo, Randy L Bell, Robert A. Mantei, Jieyi Wang, Robert D. Hubbard, Megumi Kawai, Scott A. Erickson, Nwe BaMaung, Steve D. Fidanze
  • Publication number: 20100104629
    Abstract: Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.
    Type: Application
    Filed: September 10, 2009
    Publication date: April 29, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Prasad A. Dande, Todd M. Hansen, Robert D. Hubbard, Aparna V. Sarthy, Yu Shen, Lu Tian, Carol K. Wada, Xiaobin Zhao
  • Publication number: 20100099738
    Abstract: Polyethylene glycol (PEG)-lipid conjugates, polyethylene glycol (PEG)-lipid conjugate based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.
    Type: Application
    Filed: September 10, 2009
    Publication date: April 22, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Todd M. Hansen, Robert D. Hubbard, Leiming Li, Lu Tian, Carol K. Wada, Xiaobin Zhao
  • Publication number: 20100076055
    Abstract: Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.
    Type: Application
    Filed: April 16, 2009
    Publication date: March 25, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Prasad A. Dande, Todd M. Hansen, Robert D. Hubbard, Carol K. Wada, Lu Tian, Xiaobin Zhao
  • Publication number: 20100063135
    Abstract: Polyethylene glycol (PEG)-lipid conjugates, polyethylene glycol (PEG)-lipid conjugate based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.
    Type: Application
    Filed: September 10, 2009
    Publication date: March 11, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Prasad A. Dande, Todd M. Hansen, Robert D. Hubbard, William E. Kohlbrenner, Leiming Li, Aparna V. Sarthy, Yu Shen, Lu Tian, Carol K. Wada, Xiaobin Zhao
  • Publication number: 20100055169
    Abstract: Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.
    Type: Application
    Filed: September 10, 2009
    Publication date: March 4, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Prasad A. Dande, Todd M. Hansen, Robert D. Hubbard, Aparna V. Sarthy, Yu Shen, Lu Tian, Carol K. Wada, Xiaobin Zhao
  • Publication number: 20100055168
    Abstract: Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.
    Type: Application
    Filed: September 10, 2009
    Publication date: March 4, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Prasad A. Dande, Todd M. Hansen, Robert D. Hubbard, Aparna V. Sarthy, Yu Shen, Lu Tian, Carol K. Wada, Xiaobin Zhao
  • Publication number: 20090285881
    Abstract: Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.
    Type: Application
    Filed: April 16, 2009
    Publication date: November 19, 2009
    Applicant: ABBOTT LABORATORIES
    Inventors: Prasad A. Dande, Todd M. Hansen, Robert D. Hubbard, Carol K. Wada, Lu Tian, Xiaobin Zhao